Expert Analysis

Issues To Watch At ABA's Antitrust Spring Meeting

Attorneys at Freshfields consider the future of antitrust law and competition enforcement amid agency leadership c... (more story)

Reviewing Calif. Push To Restrict Private Equity In Healthcare

A recent proposed bill in California aims to broaden the state's existing corporate practice of medicine restricti... (more story)

Unpacking Trump Admin Plans For Value-Based Care

Recent developments from the Center for Medicare and Medicaid Innovation suggest the Trump administration intends ... (more story)

Deals & Corporate Governance More

Compounders Say Shortage Of Weight Loss Drug Continues

A group of compounding pharmacies looking to keep producing copycat doses of Eli Lilly & Co's lucrative weight loss drug tirzepatide are telling a Texas federal judge that demand for the drug has "far outpaced... (more story)

Amazon, Biotech Net $1.9M Win Against Fake Supplement Sellers

A Washington federal judge has awarded biotechnology company Quincy Biosciences and Amazon a combined total of $1,895,375.40 in default judgments against several individuals who hawked counterfeit Prevagen bra... (more story)

Serial Acquisitions Are Still On The FTC's Radar

The previous administration's focus on private equity firms making serial acquisitions in the same industry may continue under the Federal Trade Commission's new leadership, an agency official said Wednesday.

PE Firm TPG Wants Endo Trust's Transfer Suit Tossed

Private equity firm TPG Capital is seeking the dismissal of a lawsuit that aims to claw back billions of dollars reaped in an allegedly unfair deal with Endo International PLC before the drugmaker went bankrupt.

Healthcare REIT Lands $140M Senior Living Mortgage Loan

Diversified Healthcare Trust borrowed a three-year, nonrecourse $140 million loan secured by a portfolio of senior living communities, the healthcare-focused real estate investment trust announced.

Two More Pharmacies Hit With Eli Lilly Weight Loss Drug Suits

Eli Lilly and Co. filed another round of lawsuits Tuesday accusing compounding pharmacies of selling copycat versions of its weight loss and diabetes medications, saying in New Jersey and Delaware federal cour... (more story)

Digital Health & Technology More

Hospital Group Urges 4th Circ. To Undo Data Access Order

Industry groups representing hospitals and health data companies have urged the Fourth Circuit to rethink its panel's dismissal of an appeal over an order forcing an electronic medical records company to let a... (more story)

Congress Demands VA Update Health Record System Costs

A bipartisan group of congressional leaders has sent a letter demanding that the U.S. Department of Veterans Affairs update its schedule and cost estimate for its problem-ridden, multibillion-dollar electronic... (more story)

Zoll Gets Parts Of Data Breach Class Action Tossed

A Massachusetts federal judge released Zoll Medical Corp. from some claims brought by a proposed class of medical device customers whose personal data was released after two ransomware attacks, but kept alive ... (more story)

Orthodontic Software Co. Hit With Data Breach Class Action

An orthodontic software company has been hit with a proposed class action in Georgia federal court over a November data breach in which the names, birth dates, medical records, insurance information, payment c... (more story)

IBM And J&J Beat 'Speculative' Data Breach Suit, For Now

A New York federal judge has tossed with leave to amend a proposed class action alleging IBM and Johnson & Johnson's healthcare arm failed to safeguard sensitive health information of thousands of patients bef... (more story)

Texas Judge Deems Lab-Test Rule Outside FDA Authority

A Texas federal judge on Monday vacated a new U.S. Food and Drug Administration rule that would have brought lab-developed tests under its regulatory authority as "medical devices," finding that the move excee... (more story)

Policy & Compliance More

Senate Panel Advances Bills Tackling Drug Patents, Pricing

A U.S. Senate panel on Thursday approved a group of bills tackling pharmaceutical patents and drug pricing, including measures that claim to address so-called patent thickets and an industry practice called "product hopping."

2nd Circ. Judge Thinks Drug Price Fight Sounds Like Antitrust

A Second Circuit judge on Thursday suggested that the federal government may be insulated from claims over its demand for lower prices for Medicare and Medicaid recipients, musing that Boehringer Ingelheim Pha... (more story)

RI Judge Hits Pause On Billions In Health Grant Funding Cuts

A Rhode Island federal judge on Thursday barred the Trump administration from moving forward, for now, with the termination of billions of dollars in grants supporting state public health programs.

Baker Donelson Elevates Health Law And Public Policy Heads

Three Baker Donelson Bearman Caldwell & Berkowitz PC shareholders have been tapped for leadership roles within the firm's national health law and public policy department.

NIH Sued By Researchers Over 'Ideological Purge' On Grants

The American Public Health Association and others sued the federal government in Massachusetts federal court on Wednesday over the cancellations of billions of dollars worth of National Institutes of Health re... (more story)

GoodRx, PBM Price-Fixing MDL Set In Rhode Island

The Judicial Panel on Multidistrict Litigation on Wednesday consolidated in Rhode Island litigation alleging that GoodRx conspired with pharmacy benefit managers, including CVS Caremark and Express Scripts, to... (more story)